tiprankstipranks
Trending News
More News >
Qt Imaging Holdings, Inc. (QTIH)
:QTIH
US Market

QT Imaging Holdings (QTIH) AI Stock Analysis

Compare
42 Followers

Top Page

QT

QT Imaging Holdings

(OTC:QTIH)

Rating:28Underperform
Price Target:
QT Imaging Holdings presents significant financial challenges, with negative profit margins and high leverage being the most critical factors. The bearish technical indicators and concerning valuation metrics further weigh on the stock's outlook. However, the recent corporate event showcasing innovative technology offers some potential upside, although overall risks remain high.

QT Imaging Holdings (QTIH) vs. SPDR S&P 500 ETF (SPY)

QT Imaging Holdings Business Overview & Revenue Model

Company DescriptionQT Imaging Holdings (QTI) is a medical technology company that specializes in developing and providing advanced imaging solutions. The company operates primarily in the healthcare sector, focusing on innovative non-invasive imaging technologies that enhance diagnostic capabilities. Their core product offerings include high-resolution imaging systems designed to improve patient outcomes by providing clearer and more accurate diagnostic images.
How the Company Makes MoneyQT Imaging Holdings makes money through the sale and leasing of its imaging equipment to healthcare providers, including hospitals, clinics, and diagnostic centers. Additionally, the company may generate revenue from service agreements for maintenance and support of their imaging systems. QTI could also engage in strategic partnerships or collaborations with other medical technology companies to expand their market reach and drive sales. Revenue may also be supplemented by research and development grants, as well as potential licensing of their proprietary imaging technologies to third parties.

QT Imaging Holdings Financial Statement Overview

Summary
QT Imaging Holdings is currently facing a challenging financial situation. Despite a positive revenue growth trajectory, the company struggles with profitability and sustainability, as highlighted by negative profit margins and high leverage. The reliance on external financing to maintain operations and a negative stockholders' equity position emphasize the potential risks and need for strategic improvements.
Income Statement
20
Very Negative
QT Imaging Holdings has shown a significant increase in revenue over the TTM period, moving from zero to $4,032,168, indicating a positive growth trajectory. However, the company is struggling with profitability, as evidenced by negative profit margins: Gross Profit Margin at 53.4%, Net Profit Margin at -375.3%, and negative EBIT and EBITDA margins, indicating substantial operational losses.
Balance Sheet
15
Very Negative
The balance sheet reveals a highly leveraged position with a negative stockholders' equity of -$9,651,660, resulting in an undefined Debt-to-Equity Ratio. The negative equity ratio highlights potential solvency issues, while assets have decreased significantly. The company's high debt level poses a significant risk.
Cash Flow
25
Negative
Cash flow analysis indicates negative free cash flow growth, with TTM free cash flow deteriorating further to -$9,461,768. The operating cash flow to net income ratio is 0.62, reflecting operational cash constraints. The company is heavily reliant on financing activities to support cash requirements, as seen from significant financing cash flow.
Breakdown
Income StatementTotal Revenue
Gross Profit
EBIT
EBITDA
Net Income Common Stockholders
Balance SheetCash, Cash Equivalents and Short-Term Investments
Total Assets
Total Debt
Net Debt
Total Liabilities
Stockholders Equity
Cash FlowFree Cash Flow
Operating Cash Flow
Investing Cash Flow
Financing Cash Flow

QT Imaging Holdings Technical Analysis

Technical Analysis Sentiment
Positive
Last Price0.79
Price Trends
50DMA
0.73
Positive
100DMA
0.58
Positive
200DMA
0.58
Positive
Market Momentum
MACD
<0.01
Positive
RSI
51.79
Neutral
STOCH
6.75
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For QTIH, the sentiment is Positive. The current price of 0.79 is below the 20-day moving average (MA) of 0.80, above the 50-day MA of 0.73, and above the 200-day MA of 0.58, indicating a neutral trend. The MACD of <0.01 indicates Positive momentum. The RSI at 51.79 is Neutral, neither overbought nor oversold. The STOCH value of 6.75 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for QTIH.

QT Imaging Holdings Risk Analysis

QT Imaging Holdings disclosed 83 risk factors in its most recent earnings report. QT Imaging Holdings reported the most risks in the “Finance & Corporate” category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 3 New Risks
1.
The issuance of Combined Company Common Stock in the Yorkville Financing after the completion of the Business Combination could result in substantial dilution, which could materially affect the trading price of the Combined Company Common Stock. Q4, 2023
2.
We may be unable to sustain revenue growth or profitability. Q4, 2023
3.
We may be required to pay certain milestones and royalties and fulfill other obligations under our license agreements with third-party licensors. Q4, 2023

QT Imaging Holdings Peers Comparison

Overall Rating
UnderperformOutperform
Sector (64)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
64
Neutral
$12.87B9.817.76%16985.65%12.28%-7.83%
60
Neutral
$107.14M-16.53%-4.15%3.49%
56
Neutral
$349.43M-7.46%-3.31%-199.23%
54
Neutral
$71.61M-88.36%-9.13%30.04%
52
Neutral
$1.90B-45.52%18.27%16.28%
50
Neutral
$367.78M7.47-24.94%-25.28%-172.20%
28
Underperform
$22.47M-1536.16%-49.53%
* Financial Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
QTIH
QT Imaging Holdings
0.79
0.09
12.86%
ICAD
iCAD
3.90
2.37
154.90%
SMLR
Semler Scientific
32.98
-3.30
-9.10%
NVCR
NovoCure
17.00
-4.46
-20.78%
MLSS
Milestone Scientific
0.91
0.23
33.82%
VREX
Varex Imaging
8.42
-7.29
-46.40%
Glossary
OutperformA stock rated as "Outperform" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests that the stock is likely to deliver higher returns compared to the average returns of other stocks in the same sector or market index. Investors might consider this stock a good buying opportunity.
NeutralA stock rated as "Neutral" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly attractive nor unattractive for investment. Investors may consider holding onto the stock, as it is not expected to either significantly outperform or underperform the market.
UnderperformA stock rated as "Underperform" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests that the stock may deliver lower returns compared to the average returns of other stocks in the same sector or market index. Investors might consider selling the stock or avoiding it as an investment.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.